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Abstract: Equine arteritis virus (EAV) is a small, positive-stranded RNA virus. The 
glycoproteins gp2b, gp3 and gp4 form a heterotrimer in the viral envelope, which is 
required for cell entry of EAV. We describe expression of the ectodomains of the proteins 
in E. coli and their refolding from inclusion bodies. After extraction of inclusion bodies 
and dialysis, Gst-, but not His-tagged proteins, refold into a soluble conformation. 
However, when dialyzed together with Gst-gp3 or with Gst-gp4, His-gp2b and His-gp4 
remain soluble and oligomers are obtained by affinity-chromatography. Thus, folding and 
oligomerization of gp2b, gp3 and gp4 in vitro are interdependent processes. 




Equine arteritis virus (EAV) is a positive-stranded RNA virus belonging to the family arteriviridae 
of the order nidovirales [1]. EAV enters cells by clathrin-mediated endocytosis [2] and newly formed 
virus particles bud into intracellular membranous compartments of the exocytic pathway. EAV 
contains seven structural proteins: the nucleocapsid protein N and six membrane proteins, the 
glycoproteins gp2b, gp3, gp4, gp5 and the unglycosylated proteins E and M [3]. The membrane 
proteins form disulfide-linked heterodimeric (gp5/M) or heterotrimeric complexes (gp2b/gp3/gp4), but 
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E is present as monomer [4–6]. N, M, and gp5 are major virion components, E occurs in virus particles 
in intermediate amounts, and gp2b, gp3 and gp4 are minor structural proteins.  
All of the structural proteins are essential for virus infectivity, but their precise function during the 
replicative cycle of EAV is not known. Gp5, M and N, but not E, gp2b, gp3, or gp4, are required for 
budding of virions, implicating the latter in virus entry [7]. Likewise, exchanging the ectodomains of 
gp5 and M of EAV with those of other arteriviruses does not change the cell tropism of the 
recombinant virus [8,9]. Thus, the recently described gp2b/gp3/gp4 complex is currently a prime 
candidate for the receptor-binding and the membrane-fusion activity of EAV. For this purpose the 
gp2b/gp3/gp4 complex probably interacts structurally or at least functionally with the myristoylated 
E-protein [5,10]. Removal of E from the EAV genome completely prevents incorporation of the 
gp2b/gp3/gp4 complex into virus particles, whereas in the absence of the gp2b/gp3/gp4 complex the 
amount of E present in virus particles is greatly reduced [7]. 
Gp2b and gp4 are typical type I membrane proteins with a cleavable N-terminal signal peptide and 
a C-terminal hydrophobic transmembrane domain. In contrast, cleavage of the signal peptide from gp3 
was not observed and it is thus possible that the protein is membrane-anchored by both of its 
hydrophobic terminal domains [7,11]. In the lumen of the endoplasmic reticulum (ER), gp2b, gp3 and 
gp4 are N-glycosylated and a disulfide-linkage is formed between gp2b and gp4. Gp2b, gp3 and gp4, 
either expressed individually or from the viral genome, are retained in the ER. After release of virus 
particles from the infected cell a further and unique protein modification occurs. The gp2b/gp4 dimer 
is rapidly and spontaneously converted into a disulfide-bonded gp2b/gp3/gp4 trimer [12]. Since 
formation of a disulfide-linkage requires the close proximity of the two participating cysteines of gp3 
and gp4, it is likely that a non-covalently linked gp2b/gp3/gp4 trimer exists prior to disulfide-bond 
formation, but this has not been verified experimentally. 
Oligomerization and folding of viral transmembrane proteins are usually interdependent processes. 
Proper folding of a protein is often dependent on the presence of a binding partner from the oligomer, 
but on the other side oligomerization requires the recognition of structural motifs present only in  
(at least partially) folded protein domains. Folding starts cotranslationally when the first prospective 
domain is completely translocated into the lumen of the ER and is aided by the addition of N-linked 
carbohydrates and by the formation and subsequent remodeling of disulfide-linkages. A quality control 
system finally ensures that misfolded proteins are retained in the ER and eventually degraded to 
prevent their exposure at the cell surface [13–15]. Since many cellular proteins and enzymes, such as 
oligosaccharide transferases, disulfidisomerases and the elements of the quality control system are 
required for folding and oligomerization of proteins in the lumen of the ER, this process is often 
difficult to reconstitute with recombinant and purified proteins, especially when they were purified 
from E.coli, which lack most enzymes for protein modification. Recently we have expressed Gp2b, 
gp3 and gp4 with the baculovirus system in insect cells, but the expression levels were very low, 
precluding further functional and structural studies with purified proteins [16]. Here we have expressed 
the ectodomains of gp2b, gp3 and gp4 in E. coli. and analyzed folding and oligomerization of a 
gp2b/gp3/gp4 complex.  




2. Results  
2.1. The Ectodomains of Gp2b, Gp3 and Gp4 Are Insoluble When Expressed in E. coli 
To express the EAV-glycoproteins in E. coli in a form likely to be soluble, it might be necessary to 
delete hydrophobic domains. Hence, we performed Kyte-Doolittle plots with gp2b, gp3 and gp4 to 
identify their hydrophobic regions [17]. Surprisingly, besides the described N- and C-terminal 
hydrophobic domains, which are likely to function as signal peptide or transmembrane region, all three 
glycoproteins contain another hydrophobic region in the middle of the molecule (Figure 1A). This 
pattern of hydrophobic domains is reminiscent of viral fusion proteins, such as the hemagglutinin of 
influenza virus, where the third hydrophobic domain functions as a fusion peptide, which is exposed at 
the surface of the molecule and inserts into the cellular membrane catalysing its fusion with the viral 
membrane [18,19]. The occurrence of three hydrophobic domains in each EAV-glycoprotein suggests 
that each contains a fusion peptide and thus supports the concept that the gp2b/gp3/gp4-complex is 
involved in membrane fusion. 
We cloned DNA sequences encoding the ectodomains of gp2b, gp3 and gp4 into pQE expression-
plasmids. The resulting constructs contained a 6xHis affinity tag instead of the N-terminal signal 
peptide and lacked the C-terminal transmembrane region. Expression of His-gp2b and His-gp4 in 
E. coli was clearly detectable by SDS-PAGE and Coomassie-staining of cellular extracts (Figure 1B), 
but His-gp3 was not expressed at all (data not shown). When cellular extracts were separated by 
centrifugation into a soluble and a particulate fraction prior to SDS-PAGE, it became obvious that both 
His-gp2b and His-gp4 are completely insoluble. We therefore replaced the N-terminal histidines by 
glutathione-S-transferase (Gst), which is supposed to increase the solubility of proteins to which it is 
attached. Nevertheless, Gst-gp2b and Gst-gp4 were still exclusively present in the particulate fraction 
of E. coli. However, fusion to Gst instead to 6xHis now allows expression of gp3, but Gst-gp3 was 
also completely insoluble (Figure 1B). Several attempts to enhance the solubility of the EAV-proteins, 
i.e., by reducing the expression time or temperature or the amount of IPTG used for induction, were 
not successful (not shown). Thus, all three glycoproteins do not fold into a soluble conformation when 
expressed in E. coli, but instead are deposited as insoluble aggregates in inclusion bodies. However, 
recent data suggested that inclusion bodies do not necessarily contain “useless”, i.e., misfolded 
proteins, but proteins present in alternative conformational states [20,21]. 
2.2. Refolding of the Ectodomains of Gp2b, Gp3 and Gp4 from Inclusion Bodies 
The inclusion bodies were extracted with denaturating agents (2 M urea, pH 12.5) to dissolve the 
aggregates and unfold the proteins. To (possibly) allow refolding of proteins [22], incompletely 
solubilized components were pelleted and the resulting supernatant was subjected to stepwise dialysis 
against buffers containing decreasing urea concentration and finally against physiological phosphate-
buffer. To analyze whether the solubilized protein were precipitated or remained soluble during this 
procedure, each dialysate was centrifuged and the resulting supernatant and pellet were subjected to 
SDS-PAGE. Whereas His-gp2b and His-gp4 completely precipitated during dialysis, Gst-gp3 and 
Gst-gp4 remained soluble indicating that the Gst-tag facilitated folding of the proteins into a soluble 




conformation (Figure 2, upper panel). In contrast, refolding of GST-Gp2b was very inefficient 
(not shown). 
Figure 1. Expression of the ectodomains of gp2b, gp3 and gp4 in E. coli and their 
accumulation in inclusion bodies. (A) Kyte-Doolittle hydropathy plots (window size 9) for 
gp2b, gp3, gp4 and for the hemagglutinin of influenza virus (Flu). The hydrophobicity 
score is plotted against the amino acid residue (position) of the respective protein. Scores 
above 2 are considered to be highly hydrophobic, i.e., are likely to insert into membranes. 
The N- and C-terminal hydrophobic regions are the proposed signal peptides and the 
transmembrane regions, respectively. The third hydrophobic region in the middle of the 
molecule, which has been shown to function as fusion peptide in the case of HA, is marked 
with a white arrow. The constructs used in this study contain the complete ectodomain of 
gp2b, gp3 and gp4, i.e., excluding the N- and C-terminal hydrophobic region. 
(B) Expression of 6 × His-tagged (upper panel) and Gst-EAV-proteins (lower panel) in 
E.coli and their accumulation in inclusion bodies. E. coli containing the respective 
expression plasmids were induced with IPTG and were grown overnight at room 
temperature. Pelleted cells were resuspended in lysis-buffer, lysed by sonication and 
centrifuged for 20 min at 5,000 × g. Aliquots of cell lysates before (–) and after (+) 
induction of protein synthesis as well as supernatants (S) and pellets (P) were subjected to 
SDS-PAGE under reducing conditions and Coomassie staining. The expressed 
EAV-proteins are marked with a black arrow. M: molecular mass markers as indicated, 
Ly: Lysozyme (14 kDa), which is added before preparation of cell lysates. 
 
 
Transmembrane proteins forming a heterooligomeric spike in virus particles often require each 
other for proper folding inside cells [14,15]. To analyze whether folding of His-gp2b and/or His-gp4 
might be positively affected by the presence of Gst-gp3 or Gst-gp4 in vitro, we combined various 
supernatants obtained from the urea extracts of inclusion bodies prior to dialysis. Strikingly, His-gp2b 
as well as His-gp4 remain (for most parts or even completely) soluble when dialyzed together with 




Gst-gp3 or with Gst-gp4 (Figure 2, lower panel). Thus, His-gp4 as well as His-gp2b can fold into a 
soluble conformation when either Gst-gp3 or Gst-gp4 is present during dialysis. 
Figure 2. Refolding of EAV proteins during dialysis of urea-extracts of inclusion bodies. 
Upper panel: Dialysis of individual EAV-proteins. Lower panel: Combined dialysis of the 
indicated combinations of EAV-proteins. Inclusion bodies were resuspended in denaturating 
buffer. After centrifugation the resulting supernatants were dialyzed against buffer with 
decreasing urea concentration and finally against physiological buffer. The dialysate was 
then centrifuged and aliquots of the supernatant (S) and of the pellet (P) were analyzed by 
SDS-PAGE under reducing conditions and Coomassie-staining. M: molecular mass marker 
as indicated, Ly: Lysozyme. Due to the lack of antibodies we were not able to confirm the 
identiy of the bands by Western blot. Nevertheless, since the recombinant proteins are the 
major proteins present in bacterial lysates (see Figure 1), we are sure that the identification 
of bands is correct. 
 
2.3. Oligomerization Is Required for Refolding of the Ectodomains of Gp2b, Gp3 and Gp4  
We tested whether oligomerization of EAV-proteins occurs during refolding. After dialysis of 
Gst-gp3, either alone or in combination with His-gp2b, or with His-gp4, or with both proteins, the 
cleared dialysate was loaded onto a glutathione-column, the column was washed, and bound proteins 
were eluted with glutathione. SDS-PAGE of these fractions shows that the His-tagged proteins are 
present together with Gst-gp3 in the eluate for all combinations (Figure 3). This must be due to the 
formation of oligomers during refolding, since lysozyme, which is added before lysis of bacteria, is 
present in the fraction which was loaded onto the column, but largely removed during affinity 
chromatography. However, it cannot be inferred from the data of the experiments involving all three 




EAV-proteins, whether a heterotrimeric complex or two heterodimers, i.e., Gst-gp3/His-gp2b and 
Gst-gp3/His-gp4, have been formed. Since the complete trimeric Gp2b/3/4 complex is very unstable, 
e.g., it does not resist purification by centrifugation through a sucrose gradient [12], we were not able 
to clarify this important question. 
Figure 3. Affinity-purification of EAV-protein oligomers. Gst-gp3, His-gp2b and His-gp4 
were expressed individually in E. coli and solubilized from inclusion bodies, and refolded 
by dialysis. Urea extracts from inclusion bodies containing Gst-gp3 were dialysed alone 
(Gst-3) or were combined with His-gp2b (Gst-3+His-2b), with His-gp4 (Gst-3His-4) or 
with both (Gst-3+His-2b+4) prior to dialysis. The cleared dialysate was then agitated with 
glutathione-beads, beads were pelleted, put in a column, and washed 5 times with 
phosphate-buffered saline. Proteins were eluted with elution buffer. Aliquots of the 
dialysate (load), of the flow-through (FT), of wash 5 (W5) and of the eluates (E) were 
subjected to SDS-PAGE under reducing conditions and Coomassie-staining. M: Molecular 
mass markers, Ly: Lysozyme. 
 
3. Experimental Section 
3.1. Expression of the Gp2b, Gp3 and Gp4 Ectodomains of EAV in E. coli 
Nucleotides encoding the ectodomains of Gp2b (amino acids 25 to 169), Gp3 (amino acids 24 
to 138) and Gp4 (amino acids 22 to 125) from the Bucyrus strain of equine arteritis virus were 
amplified with PCR from pBluescript KS plasmids and subcloned into pQE30 and pGEX-6P-1. As a 
result, each protein contains either a 6xHis or a GST-tag at its N-terminus.  




E. coli cells (strain BL21 and XL1-blue) containing the respective expression plasmids (pQE-30 
and pGEX-6P-1) were induced at an OD600 of 0.8 with 0,1 mM IPTG and were grown overnight at 
room temperature. Pelleted cells (10 min, 10.000 × g) were resuspended in lysis-buffer (20 mM Tris, 
(pH 7.4), 150mM NaCl), lysed on ice by sonication with a pobe-type sonicator and lysozyme (final 
concentration of 1 mg/mL) and DNAse I (final concentration of 40 µg/mL)) were added. The samples 
were incubated on ice for 30 minutes and centrifuged for 20 min at 5,000 × g. Aliquots of cell lysates 
before and after induction of protein synthesis as well as supernatants (containing soluble proteins) and 
pellets (inclusion bodies containing insoluble proteins) were subjected to SDS-PAGE (reducing 
conditions, 15% polyacrylamide gels) and Coomassie staining.  
3.2. Refolding of the Gp2b, Gp3 and Gp4 Ectodomains from Inclusion Bodies 
Inclusion bodies, prepared as described above, were resuspended in denaturating buffer (100 mM 
Tris, (pH 12.5), 2 M urea, 10 mL buffer was used for cells pelleted from 100 mL medium) and agitated 
for 1 hour at 4 °C. After centrifugation (10 min, 40,000 × g) the resulting supernatants were dialyzed 
(Slide-A-Lyzer with 10 kDa molecular weight cut-off), firstly for one hour against 50 mM Tris 
(pH 10.5), 1M urea, 5% glycerol, 2.5% sucrose, secondly for one hour against 50 mM Tris (pH 9.0), 
0,5M urea, 7.5% glycerol, 3.75% sucrose), and finally overnight against phosphate-buffered saline 
(pH 8) at 4 °C. The dialysate was then centrifuged (1 min, 20,000 × g) and aliquots of the supernatant 
(containing soluble proteins) and of the pellet (containing insoluble proteins) were analyzed by 
SDS-PAGE under reducing conditions and Coomassie-staining. 
3.3. Purification of the Gp2b, Gp3 and Gp4 Oligomers  
Gst-gp3, His-gp2b and His-gp4 were expressed individually in E. coli and solubilized from 
inclusion bodies as described above. Urea extracts from inclusion bodies containing Gst-gp3 were 
dialysed alone or were combined with His-gp2b, with His-gp4 or with both His-gp2b and His-gp4 
prior to dialysis. The cleared dialysate was agitated with glutathione-beads for one hour, beads were 
then pelleted (1 min, 1,000 × g), put in a column, and washed 5 times with phosphate-buffered saline 
(pH 8). Proteins were eluted with elution buffer (10 mM reduced glutathione in phosphate-buffered 
saline, pH 8). Aliquots of the dialysate, of the flow-through, of wash 5 and of the eluates were 
subjected to SDS-PAGE under reducing conditions and Coomassie-staining. 
4. Discussions and Conclusions 
In summary, we have shown that folding of the recombinant ectodomains of gp2b and gp4 in-vitro 
is enhanced by the presence of another component of the heterotrimeric complex and that the 
beneficial effect is due to the formation of oligomers. Thus, oligomerization and folding are 
interdependent processes, being in line with current knowledge on the formation of spike proteins of 
enveloped viruses, which, however, were mainly studied inside cells [14,15].  
The gp2b/gp3/gp4 complex is one of the few described virus spikes composed of three different 
proteins. Thus, pathways leading to trimerization, i.e., whether it occurs via stable dimeric 
intermediates have not been studied so far. We have observed the formation of all possible 




combination of dimers, e.g., gp2b with gp3 and with gp4 as well as gp3 with gp4. It is thus likely that 
the first step in oligomerization is formation of a dimer, which then recruits the third protein to build a 
trimer. Since gp2b, gp3 and gp4 are abundantly expressed in the cell, but only sparsely incorporated 
into virus particles, it is likely that not each combination of dimers leads to the formation of a 
functional trimeric spike.  
Surprisingly, disulfide-bonds, either intramolecular in gp2b or intermolecular between subunits of 
the gp2b/gp3/gp4-complex, which have an important function for incorporation of the gp2b/gp3/gp4 
complex into virus particles and especially for virus infectivity [6,11,12], are not essential for folding 
and oligomerization of the gp2b/gp3/gp4 complex, at least in vitro. However, since the formation of 
disulfide-bonds requires close proximity of the cysteines involved, proper folding might be a 
prerequisite for disulfide-bond formation. Likewise, N-linked carbohydrates are not required for 
folding and oligomerization, but the Gst-tag can apparently replace the glycosylation in its function of 
increasing the solubility of folding intermediates. Thus, glycosylation has no structural role, but in vivo 
it is most likely required for interaction of gp2b, gp3 and/or gp4 with elements of the quality control 
system [13,15]. Likewise, the transmembrane region (which was deleted from each construct in our 
study), especially if embedded in its natural lipid environment, might affect folding and 
oligomerization of the gp2b/gp3/gp4-complex. It thus remains to be shown whether the described 
folding and oligomerization pathway applies also to formation of the gp2b/gp3/gp4 complex in 
virus-infected cells.  
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